Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

被引：0
|
作者：
Makoto Ueno
Masafumi Ikeda
Takashi Sasaki
Fumio Nagashima
Nobumasa Mizuno
Satoshi Shimizu
Hiroki Ikezawa
Nozomi Hayata
Ryo Nakajima
Chigusa Morizane
机构：
[1] Kanagawa Cancer Centre Hospital,Department of Hepatobiliary and Pancreatic Oncology
[2] National Cancer Center Hospital East,undefined
[3] Cancer Institute Hospital of JFCR,undefined
[4] Kyorin University,undefined
[5] Aichi Cancer Centre Hospital,undefined
[6] Saitama Cancer Centre,undefined
[7] Eisai Co. Ltd.,undefined
[8] Eisai Inc.,undefined
[9] National Cancer Centre Hospital,undefined
来源：
BMC Cancer | / 20卷
关键词：
Lenvatinib; Biliary tract cancer; Cholangiocarcinoma; Gallbladder cancer; Ampulla of Vater;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment
    Kim, Richard
    Chiorean, E. Gabriela
    Amin, Manik
    Rocha-Lima, Caio Max S.
    Gandhi, Jitendra
    Harris, William P.
    Song, Tao
    Portnoy, David
    BRITISH JOURNAL OF CANCER, 2017, 117 (02) : 189 - 194
  • [12] An Analysis of a Second-Line S-1 Monotherapy for Gemcitabine-Refractory Biliary Tract Cancer
    Katayose, Yu
    Ohtsuka, Hideo
    Kitamura, Yo
    Masuda, Kunihiro
    Nakagawa, Kei
    Yamamoto, Kuniharu
    Yoshida, Hiroshi
    Onogawa, Tohru
    Motoi, Fuyuhiko
    Naitoh, Takeshi
    Rikiyama, Toshiki
    Egawa, Shin-ichi
    Unno, Michiaki
    HEPATO-GASTROENTEROLOGY, 2012, 59 (115) : 691 - 695
  • [13] Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Tober, Nastassja
    Nigro, Maria Concetta
    Mosca, Mirta
    Palloni, Andrea
    Abbati, Francesca
    Frega, Giorgio
    De Lorenzo, Stefania
    Tavolari, Simona
    Brandi, Giovanni
    ANTICANCER RESEARCH, 2020, 40 (06) : 3013 - 3030
  • [14] Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study
    Roth, Annekathrin
    Schleyer, Eberhard
    Schoppmeyer, Konrad
    Kluge, Regine
    Wittekind, Christian
    Moessner, Joachim
    Wiedmann, Marcus
    ONKOLOGIE, 2011, 34 (8-9): : 469 - 470
  • [15] Second-line chemotherapy for advanced biliary tract cancer: Results of a multicenter survey
    Vasile, E.
    Di Girolamo, S.
    Cereda, S.
    Lonardi, S.
    Leone, F.
    Russano, M.
    Silvestris, N.
    Vivaldi, C.
    Fornaro, L.
    Brandi, G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S614 - S614
  • [16] Outcome of second-line chemotherapy for biliary tract cancer
    Bridgewater, John
    Palmer, Daniel
    Cunningham, David
    Iveson, Tim
    Gillmore, Roopinder
    Waters, Justin
    Harrison, Mark
    Wasan, Harpreet
    Corrie, Pippa
    Valle, Juan
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1511 - 1511
  • [17] Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Mizuno, Suguru
    Yamamoto, Keisuke
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Togawa, Osamu
    Matsubara, Saburo
    Ito, Yukiko
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Toda, Nobuo
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 708 - 713
  • [18] Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Suguru Mizuno
    Keisuke Yamamoto
    Hiroshi Yagioka
    Yoko Yashima
    Kazumichi Kawakubo
    Hirofumi Kogure
    Osamu Togawa
    Saburo Matsubara
    Yukiko Ito
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Nobuo Toda
    Minoru Tada
    Masao Omata
    Kazuhiko Koike
    Investigational New Drugs, 2012, 30 : 708 - 713
  • [19] Capecitabine and Nab-Paclitaxel as Second-Line Treatment for Advanced Biliary Tract Cancer (ABTC): Results from a Phase II Pilot Study
    Leighton, Carly
    Brungs, Daniel
    Sjoquist, Katrin
    Chantrill, Lorraine
    Grimison, Peter
    Tognela, Annette
    Aghmesheh, Morteza
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 127 - 127
  • [20] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345